71 related articles for article (PubMed ID: 11225414)
21. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
22. [Dynamic MR-mammography in invasive lobular breast cancer].
Sittek H; Perlet C; Untch M; Kessler M; Reiser M
Rontgenpraxis; 1998; 51(7):235-42. PubMed ID: 9793406
[TBL] [Abstract][Full Text] [Related]
23. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
[TBL] [Abstract][Full Text] [Related]
24. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis of intraductal spread of breast cancer by high-resolution MR imaging: correlation between MR imaging and pathohistological findings].
Date S
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Apr; 58(5):212-20. PubMed ID: 9617156
[TBL] [Abstract][Full Text] [Related]
26. [A case of giant breast cancer performed a radical excision after neoadjuvant chemotherapy].
Matsui H; Nagashima A; Kawaoka T; Hiraki S; Fukuda S
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2487-9. PubMed ID: 20037464
[TBL] [Abstract][Full Text] [Related]
27. [MR-mammography assessment of tumor response after neoadjuvant radiochemotherapy of locally advanced breast carcinoma].
Kurtz B; Achten C; Audretsch W; Rezai M; Urban P; Zocholl G
Rofo; 1996 Jun; 164(6):469-74. PubMed ID: 8688503
[TBL] [Abstract][Full Text] [Related]
28. Potential of MR mammography to predict tumor grading of invasive breast cancer.
Dietzel M; Baltzer PA; Vag T; Zoubi R; Gröschel T; Burmeister H; Gajda M; Runnebaum IB; Kaiser WA
Rofo; 2011 Sep; 183(9):826-33. PubMed ID: 21442559
[TBL] [Abstract][Full Text] [Related]
29. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy.
Baltzer PA; Dietzel M; Vag T; Burmeister H; Gajda M; Camara O; Pfleiderer SO; Kaiser WA
Rofo; 2011 May; 183(5):441-7. PubMed ID: 21318935
[TBL] [Abstract][Full Text] [Related]
30. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study.
Delille JP; Slanetz PJ; Yeh ED; Halpern EF; Kopans DB; Garrido L
Radiology; 2003 Jul; 228(1):63-9. PubMed ID: 12775851
[TBL] [Abstract][Full Text] [Related]
31. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results.
Padhani AR; Hayes C; Assersohn L; Powles T; Makris A; Suckling J; Leach MO; Husband JE
Radiology; 2006 May; 239(2):361-74. PubMed ID: 16543585
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience.
Morris EA; Schwartz LH; Drotman MB; Kim SJ; Tan LK; Liberman L; Abramson AF; Van Zee KJ; Dershaw DD
Radiology; 2000 Jan; 214(1):67-72. PubMed ID: 10644103
[TBL] [Abstract][Full Text] [Related]
33. Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results.
Loo CE; Teertstra HJ; Rodenhuis S; van de Vijver MJ; Hannemann J; Muller SH; Peeters MJ; Gilhuijs KG
AJR Am J Roentgenol; 2008 Nov; 191(5):1331-8. PubMed ID: 18941065
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis of breast cancer extent and enhancement patterns using 3D-dynamic MR imaging: correlation with intraductal component].
Shiraishi A; Suzuki M; Nozu S; Suzuki H; Kurosumi M; Katayama H
Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Mar; 59(4):122-30. PubMed ID: 10349310
[TBL] [Abstract][Full Text] [Related]
35. MR imaging of the skin and nipple of the breast: differentiation between tumour recurrence and post-treatment change.
Ralleigh G; Walker AE; Hall-Craggs MA; Lakhani SR; Saunders C
Eur Radiol; 2001; 11(9):1651-8. PubMed ID: 11511886
[TBL] [Abstract][Full Text] [Related]
36. [The nipple in MR mammography--the normal findings and the signs of disease].
Ohmenhäuser K; Müller-Schimpfle M; Claussen CD
Rofo; 1999 Jul; 171(1):20-5. PubMed ID: 10464500
[TBL] [Abstract][Full Text] [Related]
37. MRI of breast cancer: influence of chemotherapy on sensitivity.
Rieber A; Zeitler H; Rosenthal H; Görich J; Kreienberg R; Brambs HJ; Tomczak R
Br J Radiol; 1997 May; 70(833):452-8. PubMed ID: 9227225
[TBL] [Abstract][Full Text] [Related]
38. Breast Cancer: Influence of Taxanes on Response Assessment with Dynamic Contrast-enhanced MR Imaging.
Schrading S; Kuhl CK
Radiology; 2015 Dec; 277(3):687-96. PubMed ID: 26176656
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T.
Meisamy S; Bolan PJ; Baker EH; Bliss RL; Gulbahce E; Everson LI; Nelson MT; Emory TH; Tuttle TM; Yee D; Garwood M
Radiology; 2004 Nov; 233(2):424-31. PubMed ID: 15516615
[TBL] [Abstract][Full Text] [Related]
40. MR imaging-guided focused US ablation of breast cancer: histopathologic assessment of effectiveness-- initial experience.
Gianfelice D; Khiat A; Amara M; Belblidia A; Boulanger Y
Radiology; 2003 Jun; 227(3):849-55. PubMed ID: 12714680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
